{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-106723","form_type":"8-K","ticker":"MLTX","cik":"0001821586","company_name":"MoonLake Immunotherapeutics","filed_at":"2025-11-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.616715+00:00","generated_at":"2026-05-17T00:23:29.274239+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"MoonLake Immunotherapeutics raises $75M in equity offering of 7.1M shares at $10.50/share","bullets":["Offering of 7,142,857 Class A ordinary shares at $10.50 per share for gross proceeds of $75M.","Underwriting agreement with Leerink Partners LLC; expected close on November 6, 2025.","Shares offered under existing shelf registration statement on Form S-3 (File No. 333-274286)."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-106723","json":"https://secwatch.observer/filing/0001213900-25-106723.json","markdown":"https://secwatch.observer/filing/0001213900-25-106723.md","text":"https://secwatch.observer/filing/0001213900-25-106723.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1821586/000121390025106723/0001213900-25-106723-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1821586/000121390025106723/ea0264149-8k_moonlake.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:23:29.274239+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}